Lecture 9: sympatholytics B blockers Flashcards

1
Q

Beta blocker uses

A

-angina
-arrhythmia
-post-MI
-HTN
-heart failure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Beta blocker use for angina

A

-reduces myocardial oxygen need
-decrease HR and contractility

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Beta blocker use for cardiac arrhythmia

A

-slow AV nodal conduction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Beta blocker use for post-myocardial infraction

A

-reduce myocardial oxygen need
-slow AV nodal conduction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Beta blocker use for HTN

A

-decrease CO
-inhibibit renin secretion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

beta blocker use for congestive heart failure

A

-decrease chronic overstimulation/toxicity of compensatory catecholamines

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Aryloxypropanolamines

A

-Beta ANTAgonists
-O side chain
-OH
-NH
-bulky alkyl group

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Aryloxypropanolamines structure

A

-right half (-OH, -NHR) resembles B AGONIST
-left half (aromatic ring) more lipophilic and pimary determinant of ANTAgonist activity. may also b determinant in B-1 selectivity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Nonselective B ANTAgonists

A

-propranolol
-Nadolol
-Timolol
-Pindolol
-Carteolol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Propranolol

A

-nonselective B ANTAgonist
-lipoPHILIC
-extensive first pass hepatic metabolism
-local anesthetic properties
-blockade is activity-DEPENDENT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Propranolol effects

A

-decrease CO and HR
-reduce renin release
-increase VDL
-decrease HDL
-inhibit lipolysis
-inhibit compensetory glyconeogensis and glucose release in response to hyperglycemia
-increase bronchial airway resistance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Therapeutic use of B ANTAgonists

A

-HTN
-agina
-arrhythmia
-migraine
-stage fright
-thyrotoxicosis
-glaucoma
-congestive heart failure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Nadolol

A

-non selective B-ANTAgonist
-less lipophillic than propranolol
-20 hour half life
-mostly excreted unchanged in urine
-oral admin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Nadolol uses

A

-HTN
-agina
-migraine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Timolol

A

-non-selective B ANTAgonist
-thiadiazole nucleus with morpholine ring
-oral, ophthalmic admin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Timolol uses

A

-glaucoma
-HTN
-angina
-migraine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

How will B-blockers affect pupil size?

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Timolol use in glaucoma

A

-decrease intraocular pressure
-target ciliary epithelium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Pindolol

A

-nonselective B-ANTAgonist
-possess intrinsic sympathomimetic activity (ISA)
-PARTIAL agonist
-less likely to cause BRADYcardia and lipid abnormalities
-oral admin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Pindolol uses

A

-HTN
-angina
-migraine
-good for patients with severe BRADYcardia or little cardiac reserve

21
Q

What would a pindolol dose-response curve look like?

A

-doesnt achieve full receptor activation

22
Q

Carteolol

A

-Non-selective
-ISA
-PARTIAL agonist
-less likely to cause BRADYcardia and lipid abnormalities
-oral or opththalmic admin

23
Q

Carteolol uses

A

-HTN
-glaucoma

24
Q

Selective B-1 ANTAGONISTs

A

-metaprolol and bisoprolol
-atenolol
-esmolol

25
Metoprolol and Bisoprolol
-selective B1 ANTAgonists -para phenyl derivatives -cardioselective -less bronchoconstriction -moderate lipophilicity -3-4hour half life -big first pass metabolism -oral or parenteral admin
26
Metoprolol and Bisprolol uses
-HTN -agina -antiarrythmic -congestive heart failure -oral and parenteral admin
27
Atenolol
-selective B-1 ANTAgonist -cardioselective -less bronchoconstriction -LOW lipophilicity ("water soluble metoprolol) -6-9 hour half life
28
Atenolol uses
-HTN -agina -oral and parenteral admin
29
Esmolol
-B1 ANTAgonist -9 min half life -rapid hydrolysis by ESTERASE in RBCs -incompatible with sodium bicarbonate
30
Esmolol uses
-supraventricular TACHYcardia -atrial fibrilation -perioperative HTN -parenteral admin -note compatible with sodium bicarbonate
31
Side effects of B-blockers
-BRADYcardia -AV block -sedation -symptoms of hypoglycemia -withdrawal syndrome
32
Contraindications of Beta-blockers
-asthma -COPD -congestive heart failure (type IV)
33
Mixed Adrenergic ANTAgonists
-Labetalol -cavedilol
34
Labetalol
-phenylethanolamine derivative -mixed adrenergic receptor ANTAGONIST -2 chiral carbons -racemic mix
35
Labetalol R isomer
-nonselective B-antagonist -activity prevents reflex TACHYcardia associated with a1 ANTAgonists
36
Labetalol SR isomer
-a1 ANTAgonist -vasoDILATION =prevents BRADYcardia associated with the B ANTAgonist
37
Carvedilol
-Both enantiomers antagonize a1 receptors -only S enantiomer B-ANTAgonist
38
Carvedilol S enantiomer
-non-selective B-ANTAgonist -prevents reflex TACHYcardia associated with a1 ANTAgonists
39
Carvedilol use
-HTN -congestive Heart failure -oral admin
40
Indirect-acting sympatholytics
-Metyrosine -Bretylium tosylate -reserpine
41
Metyrosine
-indirect sympatholytic -inhibits NE synthesis -inhibits tyrosine hydroxylase -depletes catecholamines everywhere
42
Metyrosine clinical use
-perioperative management of pheochromocytoma (adrenal medulla tumor that results in excessive NE and epinephrine synthesis and release)
43
Metyrosine problems
-depletes catecholamines everywhere
44
Bretylium Tosylate
-aromatic quarternary ammonium -mech unknown -displace and release NE and prevent further release -so does Guanethidine
45
Bretylium tosylate use
-reduce storage/release of NE -antiarrhytmic (ventricular fib) -parenteral admin
46
Reserpine
-indole alkaloid from root -block vesicular monoamine transporters (VMAT) -deplete vesicular pool of NE -slow onset -sustained effect (weeks)
47
Reserpine action
-VMAT IRREVERSIBLE inhibitor -depletes stored NE
48
Reserpine use
-HTN but rarely bc bad effects -may precipitate depression
49
Reserpine problems
-orthostatic hypotension -increased GI activity -CNS effects: sedation, depression, suicide